nnpNeurology, Neuropsychiatry, PsychosomaticsНеврология, нейропсихиатрия, психосоматика2074-27112310-1342"IMA-Press", LLC10.14412/2074-2711-2011-129nnp-68Research ArticleREVIEWSОБЗОРЫLow back pain: prevalence, causes, diagnosis, treatmentБоль в нижней части спины: распространенность, причины, диагностика, лечениеДубининаТ. В.DubininaT. V.
Москва
info@ima-press.netЕлисеевМ. С.EliseevM. S.
Москва
elicmax@rambler.ruНИИ ревматологии РАМНRussian Federation20111603201131NO1 (2011)2226Copyright © Dubinina T.V., Eliseev M.S., 20112011Дубинина Т.В., Елисеев М.С.Dubinina T.V., Eliseev M.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://nnp.ima-press.net/nnp/article/view/68
.
References<div><p>Wolsko P.M., Eisenberg D.M., Davis R.B. et al. Patterns and perceptions of care for treatment of back and neck pain: results of a national survey. Spine 2003;28:292-7.</p><p>Loney P.L., Stratford P.W. The prevalence of low back pain in adults: a methodological review of the literature. Phys Ther 1999;79:384-96.</p><p>Dillon C., Paulose-Ram R., Hirsch R. et al. Skeletal muscle relaxant use in the United States: data from the Third National Health and Nutrition Examination Survey (NHANES III). Spine 2004;29:892-6.</p><p>Van Tulder M.W., Koes B.W. Low Back Pain. Am Fam Physician 2002;65(5):925-9.</p><p>Hart L.G., Deyo R.A., Cherkin D.C. Physician office visits for low back pain. Frequency, clinical evaluation, and treatment patterns from a U.S. national survey. Spine 1995;20:11-9.</p><p>Volinn E. The epidemiology of low back pain in the rest of the world. A review of surveys in low- and middle-income countries. Spine 1997;22:1747-54.</p><p>Van Tulder M., Becker A., Bekkering T. et al. Chapter 3 European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J 2006;15(Suppl. 2):169-91.</p><p>Chou R., Qaseem A., Snow V. et al. Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007;147(7):478-91.</p><p>Bigos S., Bowyer O., Braen G. et al. Acute low back problems in adults. Clinical practice guideline No. 14. AHCPR publication No. 95-0642. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services. December 1994.</p><p>Эрдес Ш.Ф. Неспецифическая боль в нижней части спины. Диагностика, лечение, предупреждение. Клинические рекомендации для участковых терапевтов и врачей общей практики. М.: Комплектсервис, 2008;72 с.</p><p>Sieper J., van der Heijde D.M., Landewе R.B.M. et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise of the Assessment in SpondyloArthritis international Society (ASAS). Ann Rheum Dis 2009;68:868-72.</p><p>Deyo R.A., Rainville J., Kent D.L. What can the history and physical examination tell us about low back pain? JAMA 1992;268:760-5.</p><p>Konstantinou K., Dunn K.M. Sciatica: Review of Epidemiological Studies and Prevalence Estimates. Spine 2008;33(22):2464-72.</p><p>Воробьева О.В. Боли в нижней части спины: алгоритм диагностики и терапии. Справ поликлин врача 2003;3(2):11-5.</p><p>Koes B.W., van Tulder M.W., Ostelo R. Clinical guidelines for the management of low back pain in primary care: an international comparison. Spine 2001;26:2504-13.</p><p>Nykvist F., Hurme M., Alaranta H. et al. Severe sciatica: a 13-year follow-up of 342 patients. Eur Spine J 1995;4:335-8.</p><p>Koes B.W., van Tulder M.W., Peul W.C. Diagnosis and treatment of sciatica. BMJ 2007;334:1313-7.</p><p>Weber H., Holme I., Amlie E. The natural course of acute sciatica with nerve root symptoms in a double-blind placebo-controlled trial evaluating the effect of piroxicam. Spine 1993;18:1433-8.</p><p>Kendrick D., Fielding K., Bentley E. et al. Radiography of the lumbar spine in primary care patients with low back pain: randomized controlled trial. BMJ 2001;322:400-5.</p><p>Kerry S., Hilton S., Dundas D. et al. Radiography for low back pain: a randomized controlled trial and observational study in primary care. Br J Gen Pract 2002;52:469-74.</p><p>Jarvik J.G. Imaging of adults with low back pain in the primary care setting. Neuroimaging Clin N Am 2003;13:293-305.</p><p>Borenstein D.G., O'Mara J.W., Boden S.D. et al. The Value of Magnetic Resonance Imaging of the Lumbar Spine to Predict Low-Back Pain in Asymptomatic Subjects. A Seven-Year Follow-up Study. J Bone Joint Surg Am 2001;83:1306-11.</p><p>Patel A.T., Ogle A.A. Diagnosis and Management of Acute Low Back Pain. Am Fam Physician 2000;61:1779-90.</p><p>Humphreys S.C., Eck J.C., Hodges S.D. Neuroimaging in Low Back Pain. Am Fam Physician 2002;65:2299-306.</p><p>Atlas S.J., Deyo R.A. Evaluating and Managing Acute low Back Pain in the Primary Care Setting. J Gen Intern Med 2001;16:120-31.</p><p>Freeborn D.K., Shye D., Mullooly J. Primary care Physicians Use of Lumbar Spine Imaging Test. Effects of Guidelines and Practice Pattern Feedback. J Gen Intern Med 1997;12:619-25.</p><p>Каратеев А.Е., Яхно Н.Н., Лазебник Л.Б. и др. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации. М.: ИМА-ПРЕСС, 2009;168 с.</p><p>Chan C.C., Reid C.M., Aw T.J. et al. Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis. J Hypertens 2009;27(12):2332-41.</p><p>Ross J.S., Madigan D., Konstam M.A. et al. Persistence of cardiovascular risk after rofecoxib discontinuation. Arch Intern Med 2010;170:2035-6.</p><p>Ahmad S.R., Kortepeter C., Brinker A. et al. Renal failure associated with the use of celecoxib and rofecoxib. Drug Saf 2002;25:537-44.</p><p>Layton D., Hughes K., Harris S. et al. Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data. Rheumatology 2003;42:1354-60.</p><p>Singh G., Lanes S., Triadafilopoulos G. Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam. Am J Med 2004;117(2):100-6.</p><p>Singh G., Mannalithara A., Wang H. When COX-2 selectivity does not matter: risk of stroke with NSAIDs in patients with arthritis. Ann Rheum Dis 2007;66(Suppl. II):510.</p><p>Dreiser R.L., Le Parc J.M., Velicitat P. et al. Oral meloxicam is effective in acute sciatica: two randomised, double-blind trials versus placebo or diclofenac. Inflamm Res 2001;50(Suppl. 1):S17-S23.</p><p>Valat J.P., Accardo S., Reginster J.Y. et al. A comparison of the efficacy and tolerability of meloxicam and diclofenac in the treatment of patients with osteoarthritis of the lumbar spine. Inflamm Res 2001;50(1):30-4.</p><p>Povoroznyuk V.V., Bystrytska T.V., Orlyk T.V. Effectiveness of meloxicam for treatment of pain syndrome under knee osteoarthritis, low back and neck pain in elderly people. Osteoart Cartilage 2008;16(Suppl. 4):S23.</p><p>Euller-Ziegler L., Velicitat P. , Bluhmki E. et al. Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration. Inflamm Res 2001;50(Suppl. 1):S5-S9.</p><p>Bosch H.C., Sigmund R., Hettich M. Efficacy and tolerability of intramuscular and oral meloxicam in patients with acute lumbago: a comparison with intramuscular and oral piroxicam. Curr Med Res Opin 1997;14:29-38.</p><p>Гутянский О.Г. Применение препаратов Амелотекс и КомплигамВ в поликлинической практике у больных с болевым синдромом в области спины. РМЖ 2010;18(8):483-6.</p><p>Костина Т.Л. Купирование болевого синдрома в комплексной терапии у пациентов с диагнозом поясничный остеохондроз, синдром люмбоишалгии. РМЖ 2010;18(26):1526-7.</p><p>Логинова Г.В. Клиническая эффективность применения препаратов Амелотекс® и КомплигамВ® при вертеброгенной люмбоишалгии. Трудный пациент 2010;8(3):35-8.</p></div><br /><div><p>Wolsko P.M., Eisenberg D.M., Davis R.B. et al. Patterns and perceptions of care for treatment of back and neck pain: results of a national survey. Spine 2003;28:292-7.</p><p>Loney P.L., Stratford P.W. The prevalence of low back pain in adults: a methodological review of the literature. Phys Ther 1999;79:384-96.</p><p>Dillon C., Paulose-Ram R., Hirsch R. et al. Skeletal muscle relaxant use in the United States: data from the Third National Health and Nutrition Examination Survey (NHANES III). Spine 2004;29:892-6.</p><p>Van Tulder M.W., Koes B.W. Low Back Pain. Am Fam Physician 2002;65(5):925-9.</p><p>Hart L.G., Deyo R.A., Cherkin D.C. Physician office visits for low back pain. Frequency, clinical evaluation, and treatment patterns from a U.S. national survey. Spine 1995;20:11-9.</p><p>Volinn E. The epidemiology of low back pain in the rest of the world. A review of surveys in low- and middle-income countries. Spine 1997;22:1747-54.</p><p>Van Tulder M., Becker A., Bekkering T. et al. Chapter 3 European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J 2006;15(Suppl. 2):169-91.</p><p>Chou R., Qaseem A., Snow V. et al. Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007;147(7):478-91.</p><p>Bigos S., Bowyer O., Braen G. et al. Acute low back problems in adults. Clinical practice guideline No. 14. AHCPR publication No. 95-0642. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services. December 1994.</p><p>Эрдес Ш.Ф. Неспецифическая боль в нижней части спины. Диагностика, лечение, предупреждение. Клинические рекомендации для участковых терапевтов и врачей общей практики. М.: Комплектсервис, 2008;72 с.</p><p>Sieper J., van der Heijde D.M., Landewе R.B.M. et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise of the Assessment in SpondyloArthritis international Society (ASAS). Ann Rheum Dis 2009;68:868-72.</p><p>Deyo R.A., Rainville J., Kent D.L. What can the history and physical examination tell us about low back pain? JAMA 1992;268:760-5.</p><p>Konstantinou K., Dunn K.M. Sciatica: Review of Epidemiological Studies and Prevalence Estimates. Spine 2008;33(22):2464-72.</p><p>Воробьева О.В. Боли в нижней части спины: алгоритм диагностики и терапии. Справ поликлин врача 2003;3(2):11-5.</p><p>Koes B.W., van Tulder M.W., Ostelo R. Clinical guidelines for the management of low back pain in primary care: an international comparison. Spine 2001;26:2504-13.</p><p>Nykvist F., Hurme M., Alaranta H. et al. Severe sciatica: a 13-year follow-up of 342 patients. Eur Spine J 1995;4:335-8.</p><p>Koes B.W., van Tulder M.W., Peul W.C. Diagnosis and treatment of sciatica. BMJ 2007;334:1313-7.</p><p>Weber H., Holme I., Amlie E. The natural course of acute sciatica with nerve root symptoms in a double-blind placebo-controlled trial evaluating the effect of piroxicam. Spine 1993;18:1433-8.</p><p>Kendrick D., Fielding K., Bentley E. et al. Radiography of the lumbar spine in primary care patients with low back pain: randomized controlled trial. BMJ 2001;322:400-5.</p><p>Kerry S., Hilton S., Dundas D. et al. Radiography for low back pain: a randomized controlled trial and observational study in primary care. Br J Gen Pract 2002;52:469-74.</p><p>Jarvik J.G. Imaging of adults with low back pain in the primary care setting. Neuroimaging Clin N Am 2003;13:293-305.</p><p>Borenstein D.G., O'Mara J.W., Boden S.D. et al. The Value of Magnetic Resonance Imaging of the Lumbar Spine to Predict Low-Back Pain in Asymptomatic Subjects. A Seven-Year Follow-up Study. J Bone Joint Surg Am 2001;83:1306-11.</p><p>Patel A.T., Ogle A.A. Diagnosis and Management of Acute Low Back Pain. Am Fam Physician 2000;61:1779-90.</p><p>Humphreys S.C., Eck J.C., Hodges S.D. Neuroimaging in Low Back Pain. Am Fam Physician 2002;65:2299-306.</p><p>Atlas S.J., Deyo R.A. Evaluating and Managing Acute low Back Pain in the Primary Care Setting. J Gen Intern Med 2001;16:120-31.</p><p>Freeborn D.K., Shye D., Mullooly J. Primary care Physicians Use of Lumbar Spine Imaging Test. Effects of Guidelines and Practice Pattern Feedback. J Gen Intern Med 1997;12:619-25.</p><p>Каратеев А.Е., Яхно Н.Н., Лазебник Л.Б. и др. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации. М.: ИМА-ПРЕСС, 2009;168 с.</p><p>Chan C.C., Reid C.M., Aw T.J. et al. Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis. J Hypertens 2009;27(12):2332-41.</p><p>Ross J.S., Madigan D., Konstam M.A. et al. Persistence of cardiovascular risk after rofecoxib discontinuation. Arch Intern Med 2010;170:2035-6.</p><p>Ahmad S.R., Kortepeter C., Brinker A. et al. Renal failure associated with the use of celecoxib and rofecoxib. Drug Saf 2002;25:537-44.</p><p>Layton D., Hughes K., Harris S. et al. Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data. Rheumatology 2003;42:1354-60.</p><p>Singh G., Lanes S., Triadafilopoulos G. Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam. Am J Med 2004;117(2):100-6.</p><p>Singh G., Mannalithara A., Wang H. When COX-2 selectivity does not matter: risk of stroke with NSAIDs in patients with arthritis. Ann Rheum Dis 2007;66(Suppl. II):510.</p><p>Dreiser R.L., Le Parc J.M., Velicitat P. et al. Oral meloxicam is effective in acute sciatica: two randomised, double-blind trials versus placebo or diclofenac. Inflamm Res 2001;50(Suppl. 1):S17-S23.</p><p>Valat J.P., Accardo S., Reginster J.Y. et al. A comparison of the efficacy and tolerability of meloxicam and diclofenac in the treatment of patients with osteoarthritis of the lumbar spine. Inflamm Res 2001;50(1):30-4.</p><p>Povoroznyuk V.V., Bystrytska T.V., Orlyk T.V. Effectiveness of meloxicam for treatment of pain syndrome under knee osteoarthritis, low back and neck pain in elderly people. Osteoart Cartilage 2008;16(Suppl. 4):S23.</p><p>Euller-Ziegler L., Velicitat P. , Bluhmki E. et al. Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration. Inflamm Res 2001;50(Suppl. 1):S5-S9.</p><p>Bosch H.C., Sigmund R., Hettich M. Efficacy and tolerability of intramuscular and oral meloxicam in patients with acute lumbago: a comparison with intramuscular and oral piroxicam. Curr Med Res Opin 1997;14:29-38.</p><p>Гутянский О.Г. Применение препаратов Амелотекс и КомплигамВ в поликлинической практике у больных с болевым синдромом в области спины. РМЖ 2010;18(8):483-6.</p><p>Костина Т.Л. Купирование болевого синдрома в комплексной терапии у пациентов с диагнозом поясничный остеохондроз, синдром люмбоишалгии. РМЖ 2010;18(26):1526-7.</p><p>Логинова Г.В. Клиническая эффективность применения препаратов Амелотекс® и КомплигамВ® при вертеброгенной люмбоишалгии. Трудный пациент 2010;8(3):35-8.</p></div><br />
The authors declare that there are no conflicts of interest present.